RxDoctor Payments Data
★ My doctorsLook up a doctor →

Kayla Fenske

Family · Sarasota, FLNPI 1003698861

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 46 manufacturers, the largest accounting for just 7.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,283, more than ten times the $21 reported in 2023.

$2,760in general payments, 2019–2025

Across 128 payments — averaging $21.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$210
  • Daiichi Sankyo Inc.$194
  • Pfizer$179
  • Incyte Corporation$152
  • AbbVie$148
  • Johnson & Johnson$118
  • plus $2K from 40 others

What the payments were for

  • Food & beverage$2,760100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck10$210
Daiichi Sankyo Inc.7$194
Pfizer11$179
Incyte Corporation7$152
AbbVie6$148
Johnson & Johnson6$118
Geron Corporation5$116
Novartis5$115
Otsuka America Pharmaceutical, Inc.4$94
Takeda Pharmaceuticals U.S.A., Inc.3$92
AstraZeneca(2 entities)5$89
E.r. Squibb & Sons, L.L.C.4$85
Bristol Myers Squibb3$69
Beone Medicines USA, Inc.3$69
Lilly USA, LLC3$64
Syndax Pharmaceuticals, Inc.3$61
Sobi, Inc2$61
Puma Biotechnology, Inc.3$56
Stemline Therapeutics Inc.2$52
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$51
Bayer3$47
Dendreon Pharmaceuticals LLC2$45
Boehringer Ingelheim2$45
Eisai Inc.2$44
Sumitomo Pharma America, Inc.2$34
Jazz Pharmaceuticals Inc.1$32
Exact Sciences1$32
Pharmacosmos Therapeutics Inc.2$32
Taiho Oncology, Inc.2$31
ADC Therapeutics America, Inc.1$31
Tempus AI, Inc1$27
Hologic Sales And Service, LLC1$25
EMD Serono, Inc.1$24
Apellis Pharmaceuticals, Inc.1$23
Ipsen Biopharmaceuticals, Inc1$23
Neuronetics, Inc.1$21
Array Biopharma Inc1$21
Idorsia Pharmaceuticals US Inc1$19
Genmab U.S., Inc.1$18
GSK1$17
Nevro Corp.1$17
Astellas Pharma US Inc1$17
Menarini Silicon Biosystems, Inc.1$17
Genentech USA, Inc.1$16
Noven Therapeutics, LLC1$14
Novocure Inc.1$14

How this compares

$2,760 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide11$12,470
Atorvastatin Calcium31$247
Venlafaxine Hcl ErVenlafaxine Hcl14$239
Potassium Chloride12$190
Levothyroxine Sodium48$187
Losartan Potassium35$170
Gabapentin21$166
Metformin Hcl24$157
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide14$126
Rosuvastatin Calcium11$113
Lisinopril25$110
Pantoprazole Sodium14$69
Amlodipine Besylate18$61
Clonazepam18$48

Paid to pharmacies, not to this prescriber.

Other family in Sarasota

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →